deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT04310150

Collagen-thrombin Matrix Efficacy During Cardiac Surgery: a Prospective Randomized Controlled Trial

Sponsor: Yonsei University

Conditions Coronary Artery Disease
Interventions Collastat Floseal
Updated 6 times since 2020 Last updated: Mar 6, 2022 Started: Feb 5, 2018 Primary completion: Mar 17, 2020 Completion: Mar 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04310150, this PHASE4 trial focuses on Coronary Artery Disease and remains completed. Sponsored by Yonsei University, it has been updated 6 times since 2018, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotCompleted~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshotCompleted~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Apr 2022 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jan 2021 — Apr 2022 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Apr 2020 — Jan 2021 [monthly]

    Completed PHASE4

    First recorded

Feb 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Yonsei University
Data source: Yonsei University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations